BridgeMD
New treatment option for ADHD
Official title Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression
ClinicalTrials.gov ID: NCT07363551
What this study is testing
What is Omega-3 fatty acids?
Omega-3 fatty acids is an investigational medicine, being studied as a potential treatment for adhd.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 18
You may be able to join if
- Youth with a DSM-5 diagnosis of MDE
You likely can't join if
- Has a recent change in antidepressants or psychotherapy treatment within 4 weeks.
- Allergic to omega-3 fatty acids
The study team makes the final eligibility decision.
Where it's taking place
- Taichung, Taichung, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taichung, Taichung, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.